Sales of off-brand Ozempic ends soon

(CNN)– The crackdown on off-brand weight loss and diabetes treatment drugs is about to take effect.

A federal deadline to halt sales of these “GLP-1” medications arrives this week.

The off-brand products made by compounding pharmacies contain the same active ingredients of Ozempic, Wegovy and others.

The difference, they didn’t have the stamp of approval from the Food and Drug Administration.

Many consumers started buying these off-brand, and less expensive drugs when increased demand of the FDA sanctioned items led to major shortages.

However, a few months ago FDA officials declared the shortages were replenished.